These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M, Røde A, Westergaard J. Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [Abstract] [Full Text] [Related]
8. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol. Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A. Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317 [Abstract] [Full Text] [Related]
9. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone. Akerlund M, Almström E, Högstedt S, Nabrink M. Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352 [Abstract] [Full Text] [Related]
10. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. Rossmanith WG, Steffens D, Schramm G. Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028 [Abstract] [Full Text] [Related]
11. Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. Jandrain BJ, Humblet DM, Jaminet CB, Scheen AJ, Gaspard UJ, Lefebvre PJ. Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):378-81. PubMed ID: 2142578 [Abstract] [Full Text] [Related]
12. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S. Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587 [Abstract] [Full Text] [Related]
14. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC. Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [Abstract] [Full Text] [Related]
15. Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up. Castelo-Branco C, Martínez de Osaba MJ, Pons F, Vanrell JA. Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):79-84. PubMed ID: 9710711 [Abstract] [Full Text] [Related]
16. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Porcile A, Gallardo E. Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074 [Abstract] [Full Text] [Related]
18. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [Abstract] [Full Text] [Related]